Stavridi Flora

Stavridi Flora Internist Oncologist

Director of 4th Internal Medicine - Oncology Clinic, HYGEIA

Education & Academic Qualifications


  • MRCP I, II, III – Royal College of Physicians London, 2006
  • Certificate in Medical Oncology- Institute of Cancer Research London, 2007
  • MSc in Hospital Management Athens, 2010


  • Athens Medical School National and Kapodistriako University 1994-2000

Doctoral thesis

DNA extraction in hair follicles-Guys and St Thomas’ Hospital London, UK

Fellowship in Societies, Membership in Journal Editorial Committees

  • MRCP I, II, III -Royal College of Physicians London, 2006

  • Member of American Society of Clinical Oncology (ASCO)

  • Member of European Society of Medical Oncology (ESMO)

Work Experience

Professional Experience

  • 2010 – Consultant in Medical Oncology, Hygeia Hospital

  • 08/00-9/10 Specialty Training in Medical Oncology Royal Marsden Hospital, London, UK  Guys & St Thomas’ NHS Trust, London, UK 

Education Experience

  • Clinical Lecturer in Guys and St Thomas’ University Hospital London UK , 2007-2009 

Clinical & Research Interest

Clinical Interest:

  • Breast and Gynecological Cancer

  • GU cancer

  • GI cancer

  • CNS cancer

  • Melanoma

  • Lung Cancer

Research Interest:

  • Breast and Gynecological Cancer

Recent Publications

  • Alpha B- crystalline is a marker of aggressive breast cancer behavior but does not independently prectict for patient outcome:a combined analysis of two randomized studies. Triantafyllia Koletsa, Flora Stavridi, Mattheos Bobos, Ioannis Kostopoulos, Vassiliki Kotoula, Anastasia G Eleftheraki, Irene Konstantopoulouy, Christos Papadimitriou, Anna Batistatou, Helen Gogas, Angelos Koutras, Dimosthenis V Skarlos, George Pentheroudakis, Ioannis Efstratiou, Dimitrios Pectasides, George Pentheroudakis, Ioannis Efstratiou, Dimitrios Pectasides, George Fountzilas. BMC Clinical Pathology 2014, 14:28

  • Targeted therapeutic approaches for hormone refractory prostate cancer. Stavridi F., Karapanagiwtou E, KN Syrigos. Cancer treatment Reviews 2010

  • A Phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma . Starling N, Okines A, Cunninggham D, Allum W, Wotherspoon A, Benson M, Thompson J, Thomas J, Brown G , Riddell A, Stavridi F, Ashley S, Oates j, Chau I. Br J Canser. 2009 Jun2 ; 100(11):1725-30. Epub 2009 May 12

  • Efficacy and toxicity of nonpegylated liposomal doxorubicin in breast cancer. Stavridi F, Palmieri C. Expect Rev Anticancer Ther. 2008 Dec; 8 (12) :1859-6 

  • Experience in a UK cancer centre of weekly paclitaxel in the treatment of relapsed ovarian and primary peritoneal cancer. Linch M, Stavridi F, Hook J, Barbachano Y, Gore M, Kaye SB. Gynecol Oncol. 2008 Apr; 109 (1): 27-32. Epub 2008 Feb 8.

  • Neuroendocrine tumour of the cystic duct: a case report and literature review. Stavridi F, Chong H, Chan S, Goldsmith C, Reddy M, Glees J, Benepal T . J Gastrointestinal Cancer. 2007; 38(1): 32-33

  • A guide to Chemotherapy Regimens (pancreato hepatobiliary, Colorectal Cancer ) Stavridi F, Chau I Mediscript ltd, 2007

  • An Update on Breast Angiosarcoma Post Breast Preserving Therapy and Radiotherapy. Abbott RA, Stavridi F, Palmieri C. CME BREAST 2007;3(2):35-38